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Abstract
Background: Proteolytic processing is a common mechanism among plus strand RNA viruses and the replicases of
all plus strand RNA viruses of animals thus far characterized undergo such processing. The replicase proteins of
hepatitis E virus (HEV) are encoded by ORF1. A previous report published by our group [1] provided data that
processing potentially occurred when ORF1 (Burma strain; genotype 1) was expressed using a vaccinia virus-based
expression system.
Findings: To further test for processing and to rule out artifacts associated with the expression system, ORF1 was
re-expressed using a plasmid-based expression vector with the result that the previous processing profile could not
be confirmed. When ORF1 from an HEV infectious cDNA clone (US swine strain; genotype 3) was expressed using
the plasmid-based system, the only species detected was the 185 kDa precursor of ORF1. A putative papain-like
cysteine protease [2] had been predicted within ORF1 using the original HEV genomic sequence. However, analysis
of subsequent ORF1 sequences from a large number of HEV isolates reveals that this protease motif is not
conserved.
Conclusions: The expressed HEV ORF1 gene product does not undergo proteolytic processing, indicating that the
replicase precursor of HEV is potentially unique in this regard.
Findings
Hepatitis E virus (HEV) is the sole member of the genus
Hepevirus belonging to the family Hepeviridae [reviewed
in [3]]. HEV is a non-enveloped, plus-sense, single-
stranded RNA virus whose genome is approximately 7.2
kb in length and consists of three open reading frames
(ORFs): the 5’ proximal ORF1 of ~5100 nt which encodes
the viral replicase components; the 3’ proximal ORF2 of
~2000 nt which encodes the capsid protein; and ORF3 of
~400 nt, which encodes a phosphoprotein of unknown
function. ORF2 and ORF3 overlap and are translated from
as i n g l es u b g e n o m i cR N As p ecies. Computer-assisted
sequence alignment of the deduced translation product of
ORF1 with replicase proteins of other animal and plant
plus-strand RNA viruses led to the identification of several
common motifs, including putative methyl/guanylyl-trans-
ferase, papain-like cysteine protease (PCP), poly ADP
ribose phosphatase, helicase and RNA-dependent-RNA-
polymerase (RDRP) domains [2](see Figure 1). Of these,
activity of the methyl/guanylyl transferase, the helicase,
and the RDRP domains have been experimentally demon-
strated [4-7].
Proteolytic processing of replicase polyprotein precur-
sors into mature protein products is a common
mechanism among plus-sense RNA viruses and has
been demonstrated for all plus-sense RNA viruses of
animals. HEV is most closely related to the two genera
of the Togaviridae family, the alphavirus genus and the
rubivirus genus. The replicase precursors of the viruses
in these genera are processed into four and two mature
proteins, respectively [8,9]. For both of these genera, it
has been shown that processing regulates the synthesis
of plus- and minus-strand RNA synthesis [10,11].
Because the enzyme responsible for proteolytic proces-
sing resides within the precursor, authentic processing
occurs when the replicase precursor is expressed. Pro-
cessing of the primary HEV ORF1 translation product,
which has a putative MW of ~185 kDa, has not been
resolved. No processing was detected when ORF1 was
translated in vitro and the main product following
expression of ORF1 in a number of mammalian cell
lines was the ~185 kDa uncleaved species, however * Correspondence: tfrey@gsu.edu
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Expression of ORF1 by baculovirus in insect cells yielded
a putative total of eight cleavages [13].
With respect to our earlier study, vaccinia virus-based
expression of ORF1 derived from the human Burma
strain of HEV (genotype 1) revealed the presence of puta-
tive N- and C-terminal products of 78 kDa and 107 kDa
as well as the 185 kDa uncleaved species [1]. However,
mutation of the putative catalytic cysteine (C483) of the
predicted protease catalytic site within ORF1 did not
eliminate these products and thus it could not be ruled
out this processing might be due to the expression sys-
tem employed. Therefore, to begin this follow up study,
we tried expression of the Burma strain ORF1 using a
protease-free vector, namely a plasmid vector, VR1012
(Vical, Inc., San Diego, CA), in which expression is driven
by the human cytomegalovirus (CMV) immediate early
promoter. In this construct, ORF1 was tagged at its
N- and C-termini with FLAG and HA epitopes, respec-
tively. This time, the 185 kDa uncleaved product was
again the predominant species, however a putative N-
terminal product with an apparent molecular weight of
115 kDa was detected with no corresponding putative C-
terminal product (data not shown).
It was not clear why putative processing of ORF1 of the
Burma strain differed between the two expression sys-
tems. However an infectious cDNA clone was never
assembled from the Burma strain of HEV and therefore
to guard against artifacts due to potential mutations in
the ORF1 construct assembled from this strain, we
expressed ORF1 from pSHEV3, a cDNA clone of the US
swine strain (genotype 3) that was shown to be infectious
[14]. ORF1 from pSHEV3 was introduced into the plas-
mid vector with N-terminal FLAG and C-terminal HA
epitope tags, resulting in a construct termed pCMV-
SHEV. As shown in Figure 2A and 2B, expression of the
Burma (G1)    QCRRWLSAGFHLDPRVLVFDESAPCHCRTAIRKALSKFCCFMKWLGQECTCFLQPAEGAVGDQGHDNE 500
Mexico (G2)   QCRRWLSAGFHLDPRTLVFDESVPCSCRTTIRRIAGKFCCFMKWLGQECSCFLQPAEGLAGDQGHDNE 500
US-swine (G3) QCRRWLSAGFHLDPRVLVFDESVPCRCRTFLKKVAGKFCCFMRWLGQECTCFLEPAEGLVGDYGHDNE 500
China-T1 (G4) QCRRWLSAGFHLDPRVLVFDEAAPCRCRSFLRKAATKFCCFMRWLGQDCTCFLQPIEGRVGEQGYDNE 500
Burma         AYEGSDVDPAESAISDISGSYVVPGTALQPLYQALDLPAEIVARAGRLTATVKVSQVDGRIDCETL 566
Mexico        AYEGSDVDTAEPATLDITGSYIVDGRSLQTVYQALDLPADLVARAARLSATVTVTETSGRLDCQTM 566
US-swine      AYEGSEVDPAEPAHLDVSGTYAVHGRQLEALYRALNVPHDIAARASRLTATVELTASPDRLECRTV 566
China-T1      AFEGSDIDPAEEATVSIAGSYIVTGSQLQPLYQALGIPSDLAARASRLTATVEVSDADGRLTCKTT 566
Burma         LGNKTFRTSFVDGAVLETNGPERHNL 592 
Mexico        IGNKTFLTTFVDGARLEVNGPEQLNL 592
US-swine      LGNKTFRTTVVDGAHLEANGPEQYVL 592 
China-T1      MGNKTFSTVFTDGTQLEANGPEQYVL 592 
HEV ORF1:
M Y PCP? P XH R FLAG HA
Figure 1 Schematic diagram of expressed HEV ORF1 and multiple sequence alignment of the putative PCP domain in genotypes 1-4.
ORF1 of HEV is shown schematically as a box containing a number of motifs identified by computer-assisted homology searching [2]. The
motifs are: methyl/guanylyl transferase (M), Y domain (unknown function), papain-like cysteine protease (PCP?, the presence of which is tested in
this study), proline rich region (P), X domain (poly ADP ribose phosphatase), helicase (H) and RNA-dependent RNA polymerase domain (R). For
expression, ORF1 was amplified from pTM1HEV, a plasmid used to express ORF1 of the Burma strain of HEV (genotype 1) in our earlier study [1],
and pSHEV3, an infectious cDNA clone of the swine US strain of HEV (genotype 3)[14](obtained from X.J. Meng), by PCR using primers that
added a FLAG epitope at the N-terminus and an HA-epitope at the C-terminus of the ORF. The multiple sequence alignment consists of the
putative PCP of representative members of the four HEV genotypes (Genotype 1, Burma strain M73218; Genotype 2, Mexico strain M74506;
Genotype 3, swine US strain AF082843; Genotype 4, China T1 strain AJ272108). An alignment of 135 HEV ORF1 from HEV genomic sequences
available on GenBank revealed that the putative cysteine catalytic residue (C483, boxed) is conserved while the putative catalytic histidine
residue (H590, boxed) is present in genotype 1 sequences, but is not conserved in the other genotypes. It should be noted that the catalytic
cysteine and histidine residues of the PCP in the NS-ORF of rubella virus are conserved in all eight rubella virus genotypes (Yumei Zhou,
unpublished data).
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Figure 2 Expression of US swine HEV ORF1 and rubella virus non-structural ORF. 293T cells were transfected with 5 μgo fp C M V - S H E V
DNA using Lipofectamine-2000 (as recommended by manufacturer’s protocol) and harvested 12, 24, and 48 hours post-transfection. Mock
transfected cells were processed similarly as a negative control. The cells were washed twice with PBS and lysed with 1X NP-40 buffer (1% NP-
40, 150 mM Nacl, 50 mM Tris-HCl at pH 7.4 and 2 mM EDTA) in the presence of 1X complete mini, EDTA-free protease inhibitors (Roche). The
lysates were resolved on 8% SDS-PAGE gels followed by transfer of the contents to nitrocellulose membranes and immunoblotted with for 1 h
with anti-FLAG antibody-peroxidase conjugate from Sigma (Panel A) or anti-HA antibody- peroxidase conjugate from Roche (Panel B).
Membranes were washed 5 times with 0.05% T-TBS (0.5 ml Tween-20 in 1 L 1X TBS [20 mM Tris-HCl at pH 7.5 and 175 mM NaCl]). The
peroxidase was detected using BM Blue POD substrate (Roche). Lane1: Broad range molecular weight standard marker (Mr’s in kDa given on left
margin); Lane2: Mock transfected cells; Lanes 3-5: pCMV-SHEV-transfected cells harvested at 12, 24, and 48 hrs post-transfection (the 185 kDa
ORF1 translation product is denoted on the right margin). As a control, the nonstructural protein ORF (NS-ORF) of rubella virus was amplified
from Robo502, an infectious cDNA clone (18), by PCR using primers that added a FLAG epitope at the N-terminus and an HA-epitope at the C-
terminus of the ORF and cloned into VR1012 plasmid vector; the resulting construct was termed pCMV-NS-ORF. 293T cells were transfected with
5 μg of pCMV-NS-ORF DNA using Lipofectamine-2000 (as recommended by manufacturer’s protocol) and harvested 24 and 48 hours post-
transfection. Mock transfected cells were processed similarly as a negative control. Western blotting and probing of lysates was done as
described in the legend to Figure 2. Lane 1: Broad range molecular weight standard marker (Mr’s in kDa given on left margin); Lane 2: Mock
transfected cells; Lanes 3-4: pCMV-NS-ORF-transfected cells harvested at 24 and 48 hrs post-transfection. The 240 kDa precursor and the P150 (N-
terminal) and P90 (C-terminal) products are denoted in the right margin.
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Page 3 of 5185 kDa product was detected with both anti-FLAG and
anti-HA antibody but no other ORF1-specific products
were apparent (background bands of ~95, 90, and 55 kDa
were detected by the anti-HA antibody).
As a positive control to determine if processing of a
virus nonstructural replicase protein precursor could be
detected using this expression system, the rubella virus
nonstructural protein ORF (which corresponds to ORF1
of HEV) from an infectious cDNA clone of rubella virus
[15] was also provided with N-terminal FLAG and C-
terminal HA tags and cloned into the VR1012 vector,
yielding a construct termed pCMV-NS-ORF. As shown
in Figure 2C and 2D, when this construct was
expressed, the N-terminal P150 protein was detected
with anti-FLAG antibody and the C-terminal P90 pro-
tein was detected with anti-HA antibody. No 240 kDa
precursor product was detected with either antibody,
indicating that processing was complete.
Taken together, there is no consistent evidence that
the HEV ORF1 primary translation product undergoes
proteolytic processing. Expressed ORF1 from an Indian
strain of HEV (genotype 1) and US swine strain (geno-
type 3) exhibited no processing while potential proces-
sing products of the ORF1 of the human Burma strain
(genotype 1) were not consistent between different
expression systems and therefore are likely artifactual
[1,12]. ORF1 of the Indian strain underwent a complex
processing scheme when in expressed by baculovirus in
insect cells [13], but it must be considered that insects
are not the natural hosts for HEV. HEV in vitro geno-
mic and replicon (constructs in which the structural
proteins are replaced with reporter genes) RNA tran-
scripts that are infectious in both cell culture and ani-
mals have been available for several years [14,16-20].
Despite the potential of these systems to resolve
whether ORF1 processing occurs during replication,
convincing evidence one way or the other has yet to be
reported. Thus, HEV potentially is unique among plus-
sense RNA viruses of animals in the feature of lacking
proteolytic processing of its replicase precursor. In this
regard, the catalytic residues of the putative PCP that
was postulated to mediate processing of ORF1 were pre-
dicted on the basis of the original HEV sequence (geno-
type 1 Burma strain)[2]. Since that time, numerous
additional sequences of HEV have been reported and
four genotypes have been distinguished. A search of
GenBank yielded 135 complete genomic sequences of
HEV and alignment of ORF1 from these sequences
revealed that while the putative catalytic cysteine residue
(C483) of the predicted PCP is conserved across these
sequences, the putative catalytic histidine residue is not
(Figure 1). In fact the residue at position 590 of ORF1 is
genotype specific: H in genotype 1, L in genotype 2, and
predominantly Y in genotypes 3 and 4. Additionally, in
the recently described avian HEV the region of ORF1
containing the predicted PCP is not present, consistent
with lack of processing of ORF1 [21].
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